| P&L Statement | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 52.32 | 65.09 | 79 | 86 |
| Cost of Material Consumed | 4.26 | 5.81 | 15 | 16 |
| Change in Inventory | -0.09 | -0.09 | 0 | -0.2 |
| Gross Margins | 91.86 | 91.07 | 81.01 | 81.4 |
| Employee Benefit Expenses | 14.07 | 14.72 | 16 | 18 |
| Other Expenses | 28.21 | 36.76 | 37 | 41 |
| EBITDA | 5.87 | 7.89 | 11 | 11.2 |
| OPM | 11.22 | 12.12 | 13.92 | 13.02 |
| Other Income | 0.16 | 0.34 | 1 | 0.4 |
| Finance Cost | 0.001 | 0 | 0 | 0 |
| D&A | 3.1 | 3.4 | 3 | 3 |
| EBIT | 2.77 | 4.49 | 8 | 8.2 |
| EBIT Margins | 5.29 | 6.9 | 10.13 | 9.53 |
| PBT | 2.92 | 5.82 | 7 | 9 |
| PBT Margins | 5.58 | 8.94 | 8.86 | 10.47 |
| Tax | 0.87 | 1.68 | 2 | 3 |
| PAT | 2.05 | 4.14 | 5 | 6 |
| NPM | 3.92 | 6.36 | 6.33 | 6.98 |
| EPS | 6.83 | 13.8 | 16.67 | 20 |
| Financial Ratios | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Operating Profit Margin | 11.22 | 12.12 | 13.92 | 13.02 |
| Net Profit Margin | 3.92 | 6.36 | 6.33 | 6.98 |
| Earning Per Share (Diluted) | 6.83 | 13.8 | 16.67 | 20 |
| Assets | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Fixed Assets | 25.83 | 26.75 | 26 | 48 |
| CWIP | 0.2 | 0 | 0.5 | 1 |
| Investments | 0.01 | 0.01 | 0 | 0 |
| Trade Receivables | 10.96 | 9.35 | 11 | 12 |
| Inventory | 1.1 | 1.19 | 1.5 | 2 |
| Other Assets | 16.91 | 22.65 | 28 | 12 |
| Total Assets | 55.01 | 59.95 | 67 | 75 |
| Liabilities | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Share Capital | 3 | 3 | 3 | 3 |
| FV | 10 | 10 | 10 | 10 |
| Reserves | 39.63 | 43.77 | 49 | 55 |
| Borrowings | 0 | 0 | 0 | 0 |
| Trade Payables | 3.78 | 8.16 | 10 | 11 |
| Other Liabilities | 8.6 | 5.02 | 5 | 6 |
| Total Liabilities | 55.01 | 59.95 | 67 | 75 |
| Cash-Flow Statement | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| PBT | 2.92 | 5.82 | 7 | 9 |
| OPBWC | 6.02 | 9.22 | 11 | 12 |
| Change in Receivables | 0.69 | 1.6 | -2 | -1.1 |
| Change in Inventories | -0.09 | -0.09 | 0.4 | -0.2 |
| Change in Payables | 0.21 | 0.64 | 2 | 1.4 |
| Other Changes | 0.1 | 0.13 | -0.4 | 4.9 |
| Working Capital Change | 0.91 | 0.28 | 0 | 5 |
| Cash Generated From Operations | 6.93 | 11.5 | 11 | 17 |
| Tax | -0.94 | -1.78 | -2 | -3 |
| Cash Flow From Operations | 5.99 | 9.72 | 9 | 14 |
| Purchase of PPE | -3.23 | 0 | -2 | -25 |
| Sale of PPE | 0.004 | -4.32 | 0 | 0 |
| Cash Flow From Investment | -3.33 | -4.12 | -3 | -26 |
| Borrowing | -0.02 | -0.001 | 0 | 0 |
| Dividend | 0 | 0 | 0 | -0.3 |
| Equity | 0 | 0 | 0 | 0 |
| Others From Financing | -0.001 | 0 | 0 | 0 |
| Cash Flow from Financing | -0.02 | 0 | 0 | -0.3 |
| Net Cash Generated | 2.64 | 5.6 | 6 | -12.3 |
| Cash at the Start | 4.66 | 7.3 | 13 | 19 |
| Cash at the End | 7.3 | 12.9 | 19 | 6.7 |
Down Town Hospital Limited is one of the leading multi-specialty healthcare institutions in Northeast India, recognized for its advanced medical infrastructure and quality-driven patient care. Established with a mission to provide comprehensive and affordable healthcare services, the hospital has steadily expanded its capabilities across key specialties such as cardiology, neurology, oncology, orthopedics, critical care, and minimally invasive surgery. Backed by modern diagnostic facilities, experienced medical professionals, and a patient-centric approach, Down Town Hospital has built a strong reputation for clinical excellence and reliability. Its long-standing presence and continued investment in medical technology make it a crucial healthcare provider in the region.
The growing interest in Down Town Hospital Limited Unlisted Shares reflects the confidence investors have in India’s expanding healthcare sector, especially in organizations with a strong operational footprint in underserved regions. As demand for quality healthcare rises, hospitals with established brand value, proven patient outcomes, and sustainable service models attract meaningful interest in the pre-IPO and unlisted securities market. Down Town Hospital’s steady performance, diversification into education and training through healthcare institutions, and focus on upgrading its clinical capabilities contribute to its appeal among investors seeking long-term exposure to the healthcare sector. The company’s consistent revenue streams and essential-service nature enhance its investment attractiveness.
Looking ahead, Down Town Hospital Limited aims to strengthen its healthcare delivery network, expand its specialty offerings, and adopt new medical technologies that support better diagnostics and treatment outcomes. With increasing health awareness, rising insurance penetration, and greater demand for advanced medical services in Northeast India, the hospital is well-positioned for sustained growth. For investors, the unlisted shares offer an opportunity to participate early in the company’s journey as it continues to expand and modernize its operations. The combination of operational stability, regional dominance, and long-term sectoral growth potential makes Down Town Hospital’s unlisted equity an appealing consideration for long-term investors.
Q1. What is Down Town Hospital Limited?
Down Town Hospital Limited is a private healthcare company operating hospital and medical services in India. Its shares are currently unlisted and traded in the unlisted (pre-IPO) market.
Q2. How can I buy Down Town Hospital Limited unlisted shares?
You can buy Down Town Hospital Limited unlisted shares through registered unlisted share brokers. The transaction is completed via off-market transfer to your Demat account.
Q3. Can I sell Down Town Hospital Limited unlisted shares?
Yes, existing shareholders can sell Down Town Hospital Limited unlisted shares through unlisted share dealers, subject to buyer availability and prevailing market price.
Q4. What is the current price of Down Town Hospital Limited unlisted shares?
The price of Down Town Hospital Limited unlisted shares varies based on demand, supply, and company fundamentals. Prices are usually quoted on a per-share basis in the unlisted market.
Q5. Is investing in Down Town Hospital Limited unlisted shares risky?
Yes. Unlisted shares carry risks such as low liquidity, limited disclosures, and no guaranteed IPO timeline. Investors should assess financials and consult a qualified advisor before investing.
Q6. What documents do I need to provide for purchasing shares?
Answer: You need to provide your client master report, PAN Card, and a Cancelled Cheque if you are not transferring funds from the bank account mentioned in the CMR copy. These documents are required as per SEBI regulations.
Q7. What happens if I do not have a client master report?
Answer: If you do not have a client master report, you can ask your broker to provide it for you, as it is a necessary KYC document for the transaction.